Related Experiment Videos
Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core
1DuPont Pharmaceuticals Company, Wilmington, DE 19880-0500, USA. john.m.fevig@dupontpharma.com
Bioorganic & Medicinal Chemistry Letters
|March 27, 2001
Abstract:
The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted heterocyclic core.